Nanobiotechnology and Nanomedicine Companies

The firm commercializes a family of self-assembling nanoscale scaffolds called PuraMatrix. 3DM's materials assemble upon injection into nanofibers, serving as a scaffold for tissue regeneration.

AnyGen develops bio-new drugs and essential materials, especially new drug candidates based on physiologically active peptides, biologically functional materials, and chemical nanomaterials.

The company develops biomedical nanoparticle technology and products for research and treatment of human disease. They are developing NanoElectroPlex™, a proprietary tissue selective nanoparticle platform technology based on biodegradable macromolecular carriers.

The company has developed enabling nanotechnologies for the production of protein nanoparticles, polymer nanospheres and phospholipid nanosomes for the enhanced delivery of drugs.

Develops a nanostructured material that stops bleeding almost instantly.

Arrayit Corporation empowers the genetic, research, pharmaceutical, and diagnostic communities through the discovery, development and manufacture of proprietary life science technologies and consumables for disease prevention, treatment and cure.

Provides labelled and chemically modified oligonucleotide scaffolds for nanotechnology applications.

The company is a service partner for all aspects of oligonucleotides. It developed and produced the world's first and only translucent orthodontic systems using novel nanotechnology polymer composite products.

A life sciences R&D company with a special focus on skin cell biology. The company has established proprietary technologies for nano-liposomal formulation techniques.

The company develops and sells tools for biomedical research based on nanotechnologies. Our products range from nanoparticles in suspensions to engineered surfaces for applications within stem cell research.

Applies nanotechnology to the design and manufacture of pumps, coatings and micro-needle arrays.

Develops a family of nanocomposite materials designed to increase mechanical performance in medical applications.

The company is engaged in R&D and production of nanomaterials and nanomaterials production equipment. Production program covers mostly antibacterial products for healthcare (patches, bandages), hygiene (insoles), cleaning and food industry. The company also produces unique machines for polymerisation of nanolayers at textile materials 'INM Foulard' and exclusively distributes unique patented electrospinning devices 'MultiSpin' and electrospinning devices clima control units 'ClimaSpin'.

The company's lead product in development is Amorphous Nano-Hydroxyapaite Powder. Nano-structured hydroxyapatite has several advantages over hydroxyapatite of larger particle size in its use in bone tissue engineering due to its higher surface area and consequently higher reactivity, which offers better cellular response. In addition, nano-sized hydroxyapatite is useful as an effective surface modification agent for binding numerous biological molecules.

Design, synthesis and manufacture of biocompatible nanoparticles called nanocells.

Nano Bridging Molecules is devoted to researching, developing, manufacturing, and marketing its patented SurfLink® range of advanced medical implant surface modifications designed to render medical implants biocompatible with the human body.

The company has developed an innovative cancer treatment using magnetosomes (magnetic nanoparticles synthesized by magnetotactic bacteria), which are administered to tumors and heated by applying an alternating magnetic field. This method of treatment is called magnetic hyperthermia. The heat released by the magnetosomes induces antitumor activity.

Nanofiber Solutions designs and manufactures novel 3D nanofiber scaffolds. The company's 3D cell culture products NanoAligned and NanoECM were developed for life science research. Nanofiber Solutions novel platform technology provides researchers with more biologically realistic 3-dimensional in vivo cell culture environment.

Nanoimmunotech is a Spanish company in the Nanobiotechnology sector, founded in August 2009, recognized as EIBT (Technologically Innovative Company) and Spin-off of form the Universities of Vigo and Zaragoza. It is the first European company dedicated to the biological and physico-chemical characterization and functionalization of nanoparticles (conjugation with different molecules such as nucleid acids, enzimes, antibodies, carbohydrates, peptides) and production of specific monoclonal antibodies (on demand).

Design, synthesis, and analysis of small molecule organic compounds for the pharmaceutical industry.